Your browser doesn't support javascript.
loading
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
Heintz, Emelie; Gerber-Grote, Andreas; Ghabri, Salah; Hamers, Francoise F; Rupel, Valentina Prevolnik; Slabe-Erker, Renata; Davidson, Thomas.
Afiliação
  • Heintz E; Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Box 3657, SE 103 59, Stockholm, Sweden. emelie.heintz@sbu.se.
  • Gerber-Grote A; Center for Medical Technology Assessment (CMT), Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. emelie.heintz@sbu.se.
  • Ghabri S; Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Cologne, Germany. andreas.gerber-grote@iqwig.de.
  • Hamers FF; Department of Economic and Public Health Evaluation, Haute Autorité de Santé (HAS), Saint-Denis, France.
  • Rupel VP; Department of Economic and Public Health Evaluation, Haute Autorité de Santé (HAS), Saint-Denis, France.
  • Slabe-Erker R; Institute for Economic Research (IER), Ljubljana, Slovenia.
  • Davidson T; Institute for Economic Research (IER), Ljubljana, Slovenia.
Pharmacoeconomics ; 34(1): 59-76, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26446858
ABSTRACT

OBJECTIVES:

The objectives of this study were to review current methodological guidelines for economic evaluations of all types of technologies in the 33 countries with organizations involved in the European Network for Health Technology Assessment (EUnetHTA), and to provide a general framework for economic evaluation at a European level.

METHODS:

Methodological guidelines for health economic evaluations used by EUnetHTA partners were collected through a survey. Information from each guideline was extracted using a pre-tested extraction template. On the basis of the extracted information, a summary describing the methods used by the EUnetHTA countries was written for each methodological item. General recommendations were formulated for methodological issues where the guidelines of the EUnetHTA partners were in agreement or where the usefulness of economic evaluations may be increased by presenting the results in a specific way.

RESULTS:

At least one contact person from all 33 EUnetHTA countries (100 %) responded to the survey. In total, the review included 51 guidelines, representing 25 countries (eight countries had no methodological guideline for health economic evaluations). On the basis of the results of the extracted information from all 51 guidelines, EUnetHTA issued ten main recommendations for health economic evaluations.

CONCLUSIONS:

The presented review of methodological guidelines for health economic evaluations and the consequent recommendations will hopefully improve the comparability, transferability and overall usefulness of economic evaluations performed within EUnetHTA. Nevertheless, there are still methodological issues that need to be investigated further.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Análise Custo-Benefício / Cooperação Internacional Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment / Qualitative_research Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Análise Custo-Benefício / Cooperação Internacional Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment / Qualitative_research Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article